Exelixis Inc. Common Stock vs Planet Labs — how do they compare? Exelixis Inc. Common Stock trades at $59.92 (market cap $14.62B), while Planet Labs trades at $16.67 (market cap $6.25B). The key difference: Exelixis Inc. Common Stock is far larger — about 2.3× Planet Labs's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, Planet Labs nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Planet Labs for 4 Days on average.
| EXEL | PL | |
|---|---|---|
Market Cap | $14.62B | $6.25B |
Volume | 2,684,957 | 19,125,340 |
Sector | Health | Industrials |
52-Week High | $59.13 | $51.40 |
52-Week Low | $34.54 | $11.16 |
Typical Hold Time | 0 Days | 4 Days |
Enterprise Value | $13.95B | $5.89B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →Planet Labs operates Earth-imaging satellites and provides geospatial data products. Its imagery and analytics help governments and businesses monitor changes across the planet.
Read more on PL →